{"id":5232,"date":"2023-02-17T15:58:34","date_gmt":"2023-02-17T14:58:34","guid":{"rendered":"https:\/\/event.eortc.org\/qol-conference-2023\/?page_id=5232"},"modified":"2025-05-06T10:58:27","modified_gmt":"2025-05-06T09:58:27","slug":"home-page","status":"publish","type":"page","link":"https:\/\/event.eortc.org\/qol-conference-2025\/","title":{"rendered":"Home Page"},"content":{"rendered":"

6th<\/sup> EORTC Quality of Life<\/h1><\/div>

in Cancer Clinical Trials Conference<\/h1><\/div>

12 – 13 May 2025<\/strong>\u00a0| Barcelona, Spain<\/p>\n<\/div>

Registration<\/span><\/a><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div>

Introduction<\/h2><\/div><\/div><\/div>

We are pleased to announce that the 6th EORTC Quality of Life in Cancer Clinical Trials Conference will take place on the 12th and 13th of May 2025, in Barcelona (Spain)<\/strong>. This two-day conference will provide participants with the opportunity to learn from over 35 key opinion leaders on the recent developments in health-related quality of life (HRQOL) and patient-reported outcomes (PROs) in cancer clinical research.<\/p>\n

The sessions will cover a wide variety of topics that centre on HRQOL and PROs: development of fit-for-purpose measures, design of cancer clinical trials (including early phase trials), use in regulatory and HTA decision-making, and incorporation in daily clinical practice. Special issues relating to different cancer populations such as children, adolescents and young adults, older adults, and rare cancers will also be covered.<\/p>\n<\/div><\/div><\/div>

Invited speakers will represent different expertise and stakeholder groups, including representatives from international regulatory and health technology assessment bodies, clinicians, patient representatives, statisticians, and methodologists. They will highlight recent advancements in the conceptualisation and implementation of PROs in oncology within Europe and beyond.<\/p>\n

With this conference, we will showcase and further foster collaborations that bring people together, so that barriers to implementation of PROs can be minimised. To increase outreach to students and emerging economies, we will provide travel awards to facilitate their attendance with the goal of forging a new generation of researchers globally.<\/p>\n

We look forward to welcoming you to our conference in Barcelona!<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>

Reasons to participate<\/h2><\/div><\/div><\/div>
<\/i>

Network<\/strong> with international experts<\/strong> in oncology and QoL research<\/p>\n<\/div><\/div><\/div>

<\/i>

Enhance skills <\/strong> in implementing patient-centered research<\/p>\n<\/div><\/div><\/div>

<\/i>

Access<\/strong> cutting-edge findings to improve clinical trial designs<\/strong><\/p>\n<\/div><\/div><\/div><\/div><\/div>

Organising Committee<\/h2><\/div><\/div><\/div>
<\/a><\/span><\/div><\/div><\/div>
<\/a><\/span><\/div><\/div><\/div>
<\/a><\/span><\/div><\/div><\/div>
<\/a><\/span><\/div><\/div><\/div>
<\/span><\/a><\/span>

Dr Madeline Pe<\/strong>
\nConference Chair<\/p>\n<\/div><\/div><\/div>

<\/span><\/a><\/span>

Dagmara Kuli\u015b<\/strong>
\nConference Chair<\/p>\n<\/div><\/div><\/div>

<\/span><\/a><\/span>

Dr Johannes Giesinger<\/strong>
\nConference co-Chair<\/p>\n<\/div><\/div><\/div>

<\/span><\/a><\/span>

Prof Mogens Groenvold<\/strong>
\nConference co-Chair<\/p>\n<\/div><\/div><\/div>

<\/a><\/span><\/div><\/div><\/div>
<\/a><\/span><\/div><\/div><\/div>
<\/a><\/span><\/div><\/div><\/div>
<\/a><\/span><\/div><\/div><\/div>
<\/span><\/a><\/span>

Dr Naomi Kiyota<\/strong>
\nConference co-Chair<\/p>\n<\/div><\/div><\/div>

<\/span><\/a><\/span>

Dr Katarzyna Pogoda<\/strong>
\nConference co-Chair<\/p>\n<\/div><\/div><\/div>

<\/span><\/a><\/span>

Dr Jaap Reijneveld<\/strong>
\nConference co-Chair<\/p>\n<\/div><\/div><\/div>

<\/span><\/a><\/span>

Dr Sally Wheelwright<\/strong>
\nConference co-Chair<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div>

Programme<\/h2><\/div>

The programme for this conference, which spans across two days, will address recent advancements in health-related quality of life (HRQOL) and patient-reported outcomes (PROs) in cancer research. More details on the sessions and presentations for each day are available hereafter.<\/p>\n<\/div>

View all speakers<\/span><\/a><\/div><\/div><\/div>
<\/span><\/a><\/span>

Monday,
\n12th May<\/strong><\/p>\n<\/div>

\"Identity<\/span><\/div><\/a><\/div><\/div>
<\/span><\/a><\/span>

Tuesday,
\n13th May<\/strong><\/p>\n<\/div>

\"Hand<\/span><\/div><\/a><\/div><\/div><\/div><\/div><\/div>

European Accreditation<\/h2><\/div><\/div><\/div>
<\/i>

Europe<\/h3><\/div>

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat<\/p>\n<\/div><\/div><\/div>

<\/i>

USA<\/h3><\/div>

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat<\/p>\n<\/div><\/div><\/div>

<\/i>

Canada<\/h3><\/div>

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat<\/p>\n<\/div><\/div><\/div><\/div><\/div>

European Accreditation<\/h2><\/div><\/div><\/div>
<\/span><\/div>

The 6th EORTC Quality of Life in Cancer Clinical Trials Conference, Barcelona, Spain 12\/05\/2025 – 13\/05\/2025<\/strong>, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME\u00ae) with 11.5 European CME credits (ECMEC\u00aes). Each medical specialist should claim only those hours of credit that he\/she actually spent in the educational activity.<\/p>\n<\/div><\/div><\/div><\/div><\/div>

Registration<\/h2><\/div>
<\/div><\/div>
REGISTER HERE<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div>